Co-Authors
This is a "connection" page, showing publications co-authored by DIPEN MAHESHBHAI MARU and CHING-WEI DAVID TZENG.
Connection Strength
0.088
-
Pilot Clinical Trial of Perioperative Durvalumab and Tremelimumab in the Treatment of Resectable Colorectal Cancer Liver Metastases. Clin Cancer Res. 2021 06 01; 27(11):3039-3049.
Score: 0.049
-
SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases. Eur J Surg Oncol. 2018 05; 44(5):684-692.
Score: 0.039
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.